The Pharmaceutical Research and Manufacturers of America (PhRMA) released  Report (2012): Medicines in Development for Vaccines, profiling “nearly 300 vaccines for the prevention and treatment of a wide variety of diseases in development by America’s biopharmaceutical research companies.” The vaccines – all either currently tested in clinical trials or under review by the Food and Drug Administration – include 170 for infectious diseases, 102 for cancers and eight for neurological disorders. PhRMA noted that the report includes discussion of vaccines currently in development including:

– A genetically-modified vaccine for the treatment of pancreatic cancer.

– A therapeutic vaccine that increases the immune response against the HIV virus.

– A vaccine that protects infants against meningococcal disease, a leading cause of meningitis.

– An immunotherapeutic vaccine for the treatment of Alzheimer’s disease.

– A recombinant vaccine to prevent malaria.

REPORT: Report (2012): Medicines in Development for Vaccines

April 20, 2012

http://www.phrma.org/media/releases/nearly-300-vaccines-development-prevention-treatment-disease